Antidiabetics Market Analysis - Forecast(2021 - 2026)

Report Code: HCR 0155 Report Format: PDF + Excel (Delivery in 48 Hrs)

Antidiabetics Market Overview 

Antidiabetics Market size is valued at $ 61.5Bn by 2019 and is anticipated to grow at a CAGR of 4.6% during the forecast period 2020-2025. The Antidiabetics Market growth rate is attributed to increase as diabetes mellitus is rapidly prevalent owing to the burgeoning scale of the diabetic population, systematic diabetes therapies have now become the subject of research, with diabetes impacting middle-aged communities and adolescents throughout all income classes worldwide. Diabetes is a chronic metabolic disease in which the body is either unable to produce insulin (type 1) or unable to use the insulin (type 2) generated. Diabetes is a type of metabolic disease in which the person has high blood glucose (blood sugar), owing to inadequate insulin production, or cells of the body that do not respond to insulin or both properly. Patients with elevated sugar levels experience various symptoms such as increased thirst (polydipsia), weight loss, increased appetite (polyphagia), and frequent urination (polyuria) with a sweet smell. If untreated, diabetes causes multiple life-threatening problems, both acute and chronic. Diabetes can occur in any person, regardless of age or gender. Overweight and obese individuals are more susceptible to diabetes, and those with poor diets and less physical activity are. Diabetes can lead to several serious effects such as blindness, amputations, kidney failure and higher death risk. According to the International Diabetes Federation (IDF), the prevalence of diabetes in 2019 was 463 million, and is projected to exceed 578 million by 2030. Diabetes is one of the most significant health problems affecting about half a billion people worldwide and has reached an alarming level. Type 2 diabetes is the bulk of the responsibility, accounting for around 90 per cent of total diabetes.

Antidiabetics are widely used with the help of antidiabetic agent to treat diabetes. It helps a diabetic person regulate their blood glucose (sugar) level. It contains primarily insulin, and hypoglycemic oral agents. There are various classes of anti-diabetic drugs and their selection depends on the essence of the person's diabetes, age and situation; as well as some other factors. Hence, there is a need for effective treatment with low side effects is set to result into increasing R&D spending by pharmaceutical firms for drug development. Thus, escalating demand and adoption of antidiabetic drugs in developing as well as developed nations fuel the market growth. The total number of diabetes-related deaths accounted for 4.2 million in 2019, according to IDF's latest statistics. Moreover, diabetes and hypertension are responsible for over 80 per cent of last-stage renal diseases. Increasing the risk of other health conditions including chronic kidney disease and diabetes-related cardiovascular diseases is set to result in demand for antidiabetic drugs.

Report Coverage

The report: “Antidiabetics Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Antidiabetics Market:
By Product Types: Insulin, Drugs and Others.
By Patient Type: Pediatric, Adult and Geriatric.
By Application: Type I Diabetes and Type II Diabetes.
By Route of Administration: Insulin syringe/ Insulin pen, Insulin pump, Oral, Intravenous infusion and others.
By Geography: North America, Europe, Asia-Pacific and RoW.

Key Takeaways

  • North America dominated the Antidiabetics Market with a share of 32.6% in the year 2019.        
  • The factors such as governments’ initiatives to educate and spread awareness, improvement in diabetes treatment and products innovations are amongst the major factor projected to impel growth of Antidiabetics Market.
  • Increasing geriatric population, rising prevalence of obesity among population owing to various reasons such as unhealthy lifestyles, and stressful and round-the-clock working conditions are the key factors owing to the growth in the segment during forecast period 2020-2025.

By Product Type - Segment Analysis

On the basis of product type, insulin segment held the major share of the market in terms of revenue and is poised to grow with a CAGR of 4.2%. The reason is be attributed to high rates of usage coupled with effective therapeutic properties associated with the attributes of the product to its large market share. In addition, this segment is anticipated to gain revenue share during the forecast period 2020-2025 as a result of the introduction of new products and the potential future marketing of products currently under pipeline. Apart from this, the advent of a short-acting analogue has improved its post-prandial glucose-controlling capacity in diabetic patients of both type 1 and type 2. In addition, the segment is set to see unprecedented growth during the study period with a rise in the Type-2 diabetic patient pool. 

By Geography - Segment Analysis

North America dominated the Antidiabetics Market with a share of 32.6% in 2019. The application of Antidiabetics has grown rapidly over the last few years owing to the sophisticated healthcare facilities in this region as well as high market penetration of modern insulin products such as long-acting, rapid-acting insulin analogues and DPP-4 drugs such as Januvia, Onglyza, and Nesina, and high healthcare expenditure, patient recognition, advanced healthcare infrastructure, and reimbursement mechanisms are the major contributing factors to its large share. According to a report published by the American Diabetes Association, approximately 34.2 million Americans were living with diabetes in 2018 and about 88 million people had prediabetes in the region.

There are initiatives, such as better healthcare infrastructure, high expenditure on healthcare, favorable reimbursement policies, and penetration of long acting and rapid acting insulin analogs in countries of this region. Also, several established drug manufacturers have high penetration in the U.S. antidiabetics industry. Furthermore, increasing need for diabetes management among COVID-19 patients suffering from comorbidities, are anticipated to propel the Antidiabetics Market during the forecast period 2020-2025.

Asia Pacific is set to grow at the fastest rate during the forecast period 2020-2025 owing to the rapidly improving healthcare expenditure levels, increased prevalence of type I and type II diabetes and increased patient disposable incomes. 

Drivers – Antidiabetics Market

Growing investment in drug development to manage diabetes is set to spur industry expansion

With Increase in the prevalence of diabetes and growing investment in drug development to manage diabetes there has been an increase in new product launches by major pharmaceutical companies which is anticipated to spur industry expansion. Diabetic population is projected to reach 628.6 million by 2045, according to the European Society of Cardiology. Diabetes management requires timely intervention and medication during the entire lifetime of patients owing to a lack of curative drugs. Advancement in antidiabetic drugs has led to higher success rates and complications are minimised. For instance, various new drugs including dipeptidyl peptidase-4 inhibitors, selective sodium glucose cotransporter 2 inhibitors and unique peroxisome proliferator-activated receptor agonists are in development stages. Furthermore, with Introduction of new mechanisms have increased opportunities for combination therapies. Hence, public and organizational efforts to innovate in diabetes drugs space is set to impel the market size in near future, thereby providing a lucrative support to the Antidiabetics market globally.  

Challenges – Antidiabetics Market

Drug patent expiry and poor reimbursement policies

Many of these drugs have lost patent protection, despite the availability of numerous branded antidiabetic drugs. In the wake of enormous pressure from government and regulatory authorities, which have banned top selling drugs in different countries to promote generic drugs at lower diabetic patient costs. As a result, antidiabetic’s amount is poised to move into the market of first-generation drugs and other generic products. In addition, there is an immense unmet medical antidiabetic need that can treat numerous chronic diabetes disorders such as cardiovascular diseases, dyslipidemia, hypertension, etc. For instance, Mankind Pharma, launched anti-diabeticDynaglipt (Teneligliptin) under the drug class DPP-4 inhibitors in November 2015 in India targeting the middle to low income diabetic patient population. Another major restraint in the antidiabetics market is reduction in the efficacy of drugs over a period and can lead to other health complications.

Antidiabetics Industry Outlook

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Antidiabetics Market. In 2019, Antidiabetics Market share is fragmented by the top ten players present in the market. Antidiabetics Market top 10 companies are Astra Zeneca plc, Boehringer Ingelheim GmbH, Eli Lilly & Co., Johnson & Johnson, Mankind Pharma Ltd., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, SanofiS.A., Teva Pharmaceutical Industries Ltd. and others.

Acquisitions/Product Launches

  • In December 2019, Mankind Pharmaceuticals has signed a joint marketing agreement with Glenmark Pharmaceuticals to market an antidiabetic drug called remoglifozin in India. This has helped both companies to grow their Asia Pacific business.
  • In February 2018, Cipla co-operated with Novartis and Johnson & Johnson to market their anti-diabetic products. This partnership has resulted in the firm's expansion of its business and thus improved its market position.
1. Antidiabetics Market Overview
    1.1 Definitions and Scope
2. Antidiabetics Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Route of Administration
    2.4 Key trends by Geography
3. Antidiabetics Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Patent Analysis – Key Companies
    3.4 Pricing Analysis
4. Antidiabetics Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Antidiabetics Market – Industry Entry Scenario Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Antidiabetics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Antidiabetics Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Antidiabetics Market – By Product Types (Market Size –$Million/$Billion)
    8.1 Insulin 
        8.1.1 Premixed Insulin
        8.1.2 Rapid Acting Analog
        8.1.3 Short Acting Analog
        8.1.4 Intermediate Acting Analog
        8.1.5 Long Acting Analog
    8.2 Drugs
        8.2.1 Biguanides
        8.2.2 Alpha glucosidase inhibitors
        8.2.3 Sulphonylureas
        8.2.4 DPP-IV (Dipeptidyl Peptidase) inhibitors
        8.2.5 GLP-1 (Glucagon like peptide) agonists
        8.2.6 SGLT-II (Sodium Glucose Transport Proteins) inhibitors
        8.2.7 Meglitinides
        8.2.8 Thiazolidinedione
    8.3 Others 
9. Antidiabetics Market - By Patient Type (Market Size – $Million/$Billion)
    9.1 Pediatric
    9.2 Adult
    9.3 Geriatric
10. Antidiabetics Market - By Application(Market Size – $Million/$Billion)
    10.1 Type I Diabetes
    10.2 Type II Diabetes
11. Antidiabetics Market - By Route of Administration (Market Size – $Million/$Billion)
    11.1 Insulin syringe/ Insulin pen 
    11.2 Insulin pump
    11.3 Oral
    11.4 Intravenous infusion
    11.5 Others
12. Antidiabetics Market - By Geography (Market Size – $Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Antidiabetics Market - Entropy
14. Antidiabetics Market – Industry/Segment Competition Landscape Premium 
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Best Practices for Companies
15. Antidiabetics Market – Key Company List by Country Premium Premium
16. Antidiabetics Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables:

Table 1: Antidiabetics Market Analysis Overview 2021-2026
Table 2: Antidiabetics Market Analysis Leader Analysis 2018-2019 (US$)
Table 3: Antidiabetics Market Analysis Product Analysis 2018-2019 (US$)
Table 4: Antidiabetics Market Analysis End User Analysis 2018-2019 (US$)
Table 5: Antidiabetics Market Analysis Patent Analysis 2013-2018* (US$)
Table 6: Antidiabetics Market Analysis Financial Analysis 2018-2019 (US$)
Table 7: Antidiabetics Market Analysis Driver Analysis 2018-2019 (US$)
Table 8: Antidiabetics Market Analysis Challenges Analysis 2018-2019 (US$)
Table 9: Antidiabetics Market Analysis Constraint Analysis 2018-2019 (US$)
Table 10: Antidiabetics Market Analysis Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Antidiabetics Market Analysis Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Antidiabetics Market Analysis Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Antidiabetics Market Analysis Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Antidiabetics Market Analysis Degree of Competition Analysis 2018-2019 (US$)
Table 15: Antidiabetics Market Analysis Value Chain Analysis 2018-2019 (US$)
Table 16: Antidiabetics Market Analysis Pricing Analysis 2021-2026 (US$)
Table 17: Antidiabetics Market Analysis Opportunities Analysis 2021-2026 (US$)
Table 18: Antidiabetics Market Analysis Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Antidiabetics Market Analysis Supplier Analysis 2018-2019 (US$)
Table 20: Antidiabetics Market Analysis Distributor Analysis 2018-2019 (US$)
Table 21: Antidiabetics Market Analysis Trend Analysis 2018-2019 (US$)
Table 22: Antidiabetics Market Analysis Size 2018 (US$)
Table 23: Antidiabetics Market Analysis Forecast Analysis 2021-2026 (US$)
Table 24: Antidiabetics Market Analysis Sales Forecast Analysis 2021-2026 (Units)
Table 25: Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 26: Antidiabetics Market Analysis By Drugs Type, Revenue & Volume,By Insulin, 2021-2026 ($)
Table 27: Antidiabetics Market Analysis By Drugs Type, Revenue & Volume,By Rapid acting, 2021-2026 ($)
Table 28: Antidiabetics Market Analysis By Drugs Type, Revenue & Volume,By Long acting, 2021-2026 ($)
Table 29: Antidiabetics Market AnalysisBy Drugs Type, Revenue & Volume,By Sulphonylureas, 2021-2026 ($)
Table 30: Antidiabetics Market AnalysisBy Drugs Type, Revenue & Volume,By Biguanides, 2021-2026 ($)
Table 31: North America Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 32: South america Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 33: Europe Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 34: APAC  Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 35: Middle East & Africa Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 36: Russia Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 37: Israel Antidiabetics Market Analysis, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 38: Top Companies 2018 (US$)Antidiabetics Market Analysis, Revenue & Volume
Table 39: Product Launch 2018-2019 Antidiabetics Market Analysis, Revenue & Volume
Table 40: Mergers & Acquistions 2018-2019 Antidiabetics Market Analysis, Revenue & Volume


List of Figures:

Figure 1: Overview of Antidiabetics Market Analysis 2021-2026
Figure 2: Market Share Analysis for Antidiabetics Market Analysis 2018 (US$)
Figure 3: Product Comparison in Antidiabetics Market Analysis 2018-2019 (US$)
Figure 4: End User Profile for Antidiabetics Market Analysis 2018-2019 (US$)
Figure 5: Patent Application and Grant in Antidiabetics Market Analysis 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antidiabetics Market Analysis 2018-2019 (US$)
Figure 7: Market Entry Strategy in Antidiabetics Market Analysis 2018-2019
Figure 8: Ecosystem Analysis in Antidiabetics Market Analysis 2018
Figure 9: Average Selling Price in Antidiabetics Market Analysis 2021-2026
Figure 10: Top Opportunites in Antidiabetics Market Analysis 2018-2019
Figure 11: Market Life Cycle Analysis in Antidiabetics Market Analysis
Figure 12: Global By Drugs Type Antidiabetics Market Analysis Revenue, 2021-2026 ($)
Figure 13: Global Antidiabetics Market Analysis - By Geography
Figure 14: Global Antidiabetics Market Analysis Value & Volume, By Geography, 2021-2026 ($) 
Figure 15: Global Antidiabetics Market Analysis CAGR, By Geography, 2021-2026 (%)
Figure 16: North America Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 17: US Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Antidiabetics Market Analysis South America 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 30: Brazil Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Antidiabetics Market AnalysisCosta Rica 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 59: U.K Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 92: China Antidiabetics Market AnalysisValue & Volume, 2021-2026
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Antidiabetics Market AnalysisChina Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Antidiabetics Market AnalysisTaiwan 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Antidiabetics Market AnalysisMalaysia 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Antidiabetics Market AnalysisHong Kong 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Antidiabetics Market AnalysisMiddle East & Africa 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 121: Russia Antidiabetics Market AnalysisRussia 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Antidiabetics Market Analysis Value & Volume, 2021-2026 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129:  Entropy Share, By Strategies, 2018-2019* (%)Antidiabetics Market Analysis
Figure 130:  Developments, 2018-2019*Antidiabetics Market Analysis
Figure 131: Company 1 Antidiabetics Market Analysis Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Antidiabetics Market Analysis Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Antidiabetics Market Analysis Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Antidiabetics Market Analysis Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Antidiabetics Market Analysis Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Antidiabetics Market Analysis Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Antidiabetics Market Analysis Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Antidiabetics Market Analysis Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Antidiabetics Market Analysis Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Antidiabetics Market Analysis Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Antidiabetics Market Analysis Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Antidiabetics Market Analysis Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Antidiabetics Market Analysis Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Antidiabetics Market Analysis Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Antidiabetics Market Analysis Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Antidiabetics Market Analysis Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Antidiabetics Market Analysis Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Antidiabetics Market Analysis Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13Antidiabetics Market Analysis Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Antidiabetics Market Analysis  Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Antidiabetics Market Analysis  Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Antidiabetics Market Analysis  Net Sales Share, By Geography, 2018 (%)